Skip to content
Abierto
Menu

Combined synopsis and solicitation

Illumina MiniSeq DNA RNA Next Generation Sequencer (NGS) device, or equal, plus four (4) years of post-warranty maintenance

75F40124Q122894

Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.

View on SAM.govMarkdown

Awarded

Illumina, Inc.

$50,000.00 obligated so far on USAspending

Description

As published on SAM.gov.

See attached Request for quote (RFQ) for an Illumina MiniSeq DNA RNA Next Generation Sequencer (NGS) device, or equal, plus four (4) years of post-warranty maintenance. Ensure you read and follow the provision at FAR 52.212-1 "Instructions to Offerors - Commercial Products and Commercial Services (Sep 2023)" on page 19 in order to be responsive to this solicitation.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Illumina, Inc.
UEI
KMW3CRWNAAF3
CAGE
1WCS2
Vendor location
San Diego, CA
Contract
75F40124P00173, purchase order
Obligated
$50,000.00, potential $86,106
Actions
1 between May 24, 2024 and May 24, 2024
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Illumina Miniseq Dna Rna Next Generation Sequencer (Ngs) Device Plus Four (4) Option Years of Post-Warranty Maintenance (Pm and Repair Agreement)
Match
solicitation number 75F40124Q122894 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 7, 2024

    Combined synopsis and solicitation, originally sources sought

    Due May 14, 2024 at 10:00 AM EDT. SAM.gov, notice 70c2ed6e838a46d492e02c56b4d121ca

Points of contact

Also open from this buyer